Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2 - PubMed (original) (raw)
. 2002 Dec 27;277(52):50422-30.
doi: 10.1074/jbc.M209340200. Epub 2002 Oct 21.
Affiliations
- PMID: 12393857
- DOI: 10.1074/jbc.M209340200
Free article
Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2
Aylin C Hanyaloglu et al. J Biol Chem. 2002.
Free article
Abstract
G-protein-coupled receptors (GPCRs) are regulated by a complex network of mechanisms such as oligomerization and internalization. Using the GPCR subtypes for thyrotropin-releasing hormone (TRHR1 and TRHR2), the aim of this study was to determine if subtype-specific differences exist in the trafficking process. If so, we wished to determine the impact of homo- and hetero-oligomerization on TRHR subtype trafficking as a potential mechanism for the differential cellular responses induced by TRH. Expression of either beta-arrestin 1 or 2 promoted TRHR1 internalization. In contrast, only beta-arrestin 2 could enhance TRHR2 internalization. The preference for beta-arrestin 2 by TRHR2 was supported by the impairment of TRHR2 trafficking in mouse embryonic fibroblasts (MEFs) from either a beta-arrestin 2 knockout or a beta-arrestin 1/2 knockout, while TRHR1 trafficking was only abolished in MEFs lacking both beta-arrestins. The differential beta-arrestin-dependence of TRHR2 was directly measured in live cells using bioluminescence resonance energy transfer (BRET). Both BRET and confocal microscopy were also used to demonstrate that TRHR subtypes form hetero-oligomers. In addition, these hetero-oligomers have altered internalization kinetics compared with the homo-oligomer. The formation of TRHR1/2 heteromeric complexes increased the interaction between TRHR2 and beta-arrestin 1. This may be due to conformational differences between TRHR1/2 hetero-oligomers versus TRHR2 homo-oligomers as a mutant TRHR1 (TRHR1 C335Stop) that does not interact with beta-arrestins, could also enhance TRHR2/beta-arrestin 1 interaction. This study demonstrates that TRHR subtypes are differentially regulated by the beta-arrestins and also provides the first evidence that the interactions of TRHRs with beta-arrestin may be altered by hetero-oligomer formation.
Similar articles
- Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer.
Kroeger KM, Hanyaloglu AC, Seeber RM, Miles LE, Eidne KA. Kroeger KM, et al. J Biol Chem. 2001 Apr 20;276(16):12736-43. doi: 10.1074/jbc.M011311200. Epub 2001 Jan 18. J Biol Chem. 2001. PMID: 11278883 - Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
Jones BW, Hinkle PM. Jones BW, et al. J Biol Chem. 2005 Nov 18;280(46):38346-54. doi: 10.1074/jbc.M502918200. Epub 2005 Sep 23. J Biol Chem. 2005. PMID: 16183993 - Receptors for hypothalamic releasing hormones TRH and GnRH: oligomerization and interactions with intracellular proteins.
Pfleger KD, Kroeger KM, Eidne KA. Pfleger KD, et al. Semin Cell Dev Biol. 2004 Jun;15(3):269-80. doi: 10.1016/j.semcdb.2003.12.016. Semin Cell Dev Biol. 2004. PMID: 15125890 Review. - _β_-Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives.
Wess J, Oteng AB, Rivera-Gonzalez O, Gurevich EV, Gurevich VV. Wess J, et al. Pharmacol Rev. 2023 Sep;75(5):854-884. doi: 10.1124/pharmrev.121.000302. Epub 2023 Apr 7. Pharmacol Rev. 2023. PMID: 37028945 Free PMC article. Review.
Cited by
- Genetically encoded tools for in vivo G-protein-coupled receptor agonist detection at cellular resolution.
Kroning KE, Wang W. Kroning KE, et al. Clin Transl Med. 2022 Dec;12(12):e1124. doi: 10.1002/ctm2.1124. Clin Transl Med. 2022. PMID: 36446954 Free PMC article. Review. - Persistent signaling by thyrotropin-releasing hormone receptors correlates with G-protein and receptor levels.
Boutin A, Allen MD, Neumann S, Gershengorn MC. Boutin A, et al. FASEB J. 2012 Aug;26(8):3473-82. doi: 10.1096/fj.12-207860. Epub 2012 May 16. FASEB J. 2012. PMID: 22593547 Free PMC article. - Cell type influences the molecular mechanisms involved in hormonal regulation of ERG K+ channels.
Carretero L, Barros F, Miranda P, Fernández-Trillo J, Machín A, de la Peña P, Domínguez P. Carretero L, et al. Pflugers Arch. 2012 Apr;463(5):685-702. doi: 10.1007/s00424-012-1094-y. Epub 2012 Mar 14. Pflugers Arch. 2012. PMID: 22415214 - CRH-stimulation of cyclic adenosine 5'-monophosphate pathway is partially inhibited by the coexpression of CRH-R1 and CRH-R2alpha.
Maya-Núñez G, Castro-Fernández C, Méndez JP. Maya-Núñez G, et al. Endocrine. 2005 Jun;27(1):67-73. doi: 10.1385/endo:27:1:067. Endocrine. 2005. PMID: 16077174 - Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells.
Pfleger KD, Eidne KA. Pfleger KD, et al. Biochem J. 2005 Feb 1;385(Pt 3):625-37. doi: 10.1042/BJ20041361. Biochem J. 2005. PMID: 15504107 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources